Last Updated On 6/2/2022 8:43:27 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: immunomedics |
| Recipient: You |
| Company: Celgene |
| Recipient: You |
| Company: Genentech/Roche |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: Abbvie |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: Athenex |
| Recipient: You |
| Company: G1 Therapeutics |
| Recipient: You |
| Company: Puma Biotechnology |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Signatera |
| Recipient: You |
| Company: Arvinas |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Merck |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Genentech/Roche |
| Recipient: Your Institution |
| Company: Daiichi Sankyo |
| Recipient: Your Institution |
| Company: GlaxoSmithKline |
| Recipient: Your Institution |
| Company: G1 Therapeutics |
| Recipient: Your Institution |
| Company: Arvinas |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| Company: Medscape |
| Recipient: You |
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|